These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1362020

  • 1. HTLV-II-specific antisera raised in rabbits immunized with a synthetic peptide of HTLV-II envelope protein.
    Hayashi K, Ohara N, Fujiwara K, Jeon HJ, Koirala TR, Takahashi K, Akagi T, Tomita N, Miyamoto K.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 63(1):37-41. PubMed ID: 1362020
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Detection of human T-lymphotropic virus type-I/II env antibodies by immunoassays using recombinant fusion proteins.
    Rudolph DL, Khabbaz RF, Folks TM, Lal RB.
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):35-9. PubMed ID: 8102953
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ, Tanner ME, Scearce RM, Streilein RD, Clark ME, Haynes BF.
    J Immunol; 1989 Feb 01; 142(3):971-8. PubMed ID: 2563272
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.
    Lal RB, Rudolph DL, Lairmore MD, Khabbaz RF, Garfield M, Coligan JE, Folks TM.
    J Infect Dis; 1991 Jan 01; 163(1):41-6. PubMed ID: 1984475
    [Abstract] [Full Text] [Related]

  • 16. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
    Desgranges C, Souche S, Vernant JC, Smadja D, Vahlne A, Horal P.
    AIDS Res Hum Retroviruses; 1994 Feb 01; 10(2):163-73. PubMed ID: 8198868
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E, Nakamura M, Tanaka Y, Kuroki M, Itoyama Y, Nakano S, Niho Y.
    J Immunol; 1993 Jul 15; 151(2):1013-24. PubMed ID: 7687611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.